Sugammadex Sodium Solution
Product Images NDC 42023-830

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sugammadex Sodium (NDC 42023-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Pfs Foil Label 2ml)

Label for Sugammadex Injection with 200 mg/2 mL (100 mg/mL) concentration in a 2 mL single-dose prefilled syringe. Intended for intravenous use, labeled by Par Health USA, LLC. The label includes storage instructions, lot and expiration date fields, and barcode information. The packaging notes a peel-here feature and a warning zone marked by a blue band.*

FDA Label Image

Carton Label-5 mL (Pfs Foil Label 5ml)

SUGAMMADEX Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use in a 5 mL single-dose prefilled syringe. Labeler is Par Health USA, LLC. The label includes storage instructions and usage precautions, and is white with orange and black text.*

FDA Label Image

Prefilled Syringe Label (Pfs Label 2ml)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The label indicates a 2 mL single-dose prefilled syringe, with storage instructions to protect from light at 25°C (77°F). Manufactured by OneSource Specialty Pharma Limited, India, and labeled for Par Health USA, Rochester, MI, USA. Includes barcode and lot/expiration placeholders.*

FDA Label Image

Prefilled Syringe Label-5 mL (Pfs Label 5ml)

Label for Sugammadex Injection 500 mg/5 mL solution for intravenous use. The label indicates a 5 mL single-dose prefilled syringe, strength of 100 mg/mL, with storage instructions at 25°C and protection from light. Manufactured by OneSource Specialty Pharma Limited in India for Par Health USA, LLC. Includes barcode and NDC 42023-935-01.*

FDA Label Image

Prefilled Syringe Blister Foil Label (Carton Label 2 mL)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The label indicates the product comes in 10 single-dose prefilled syringes of 2 mL each. The labeler is Par Health USA, LLC. The label includes usage instructions, storage information, and manufacturer details from OneSource Specialty Pharma Limited, India, with Par Health USA listed as the U.S. manufacturer.*

FDA Label Image

Prefilled Syringe Blister Foil Label-5 mL (Carton Label 5 mL)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The label indicates a package size of 10 single-dose prefilled syringes, manufactured by Par Health USA, LLC. The label includes dosage and storage information, NDC 42023-935-10, and features the Par Health logo.*

FDA Label Image

Image Description (Figure 1)

A cumulative recovery rate versus time to recovery (minutes) line graph comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg following rocuronium use. The graph shows faster recovery times with sugammadex (median 1.4 minutes) than neostigmine (median 21.5 minutes). The plot includes median recovery times with quartiles and censored observations noted.*

FDA Label Image

Image Description (Figure 2)

A cumulative recovery rate Kaplan-Meier curve comparing recovery times with sugammadex 2 mg/kg versus neostigmine 0.05 mg/kg after vecuronium administration. The x-axis represents time to recovery in minutes, and the y-axis cumulative recovery rate. A legend identifies the line types for each treatment group and notes sample sizes. Median recovery times for sugammadex and neostigmine are shown with quartile ranges.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure of Sugammadex Sodium, depicted as a cyclic molecular arrangement with multiple sugar units and sodium carboxylate groups.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of Sugammadex Sodium showing a complex cyclic molecule with multiple sugar-like units and sodium carboxylate groups. The structure highlights the arrangement of oxygen, sulfur atoms, and hydroxyl groups characteristic of this intravenous solution.*

FDA Label Image

Image Description (Syringe Image 1)

An illustration of a syringe labeled with instructions showing the syringe tip cap that should be removed and the plunger rod which should not be removed. The syringe is transparent with black plunger components and a green circular flange near the handle.*

FDA Label Image

Image Description (Syringe Image 2)

An instructional illustration showing how to use a syringe with a vial or connector, including a hand turning the syringe cap and labeled parts A, B, and C of the syringe or vial connection mechanism.*

FDA Label Image

Image Description (Syringe Image 3)

Illustration showing the assembly and use of a syringe with labeled parts A, B, and C. The left side depicts a hand holding a syringe, with an arrow pointing upward indicating removal or attachment of a component, while the right side shows detailed views of parts labeled A, B, and C of the syringe or connector.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.